Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Shares Outstanding (Weighted Average) (2016 - 2025)

InspireMD (NSPR) has 16 years of Shares Outstanding (Weighted Average) data on record, last reported at $73.5 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 51.89% year-over-year to $73.5 million; the TTM value through Sep 2025 reached $73.5 million, up 51.89%, while the annual FY2024 figure was $41.9 million, 72.77% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $73.5 million in Q3 2025 per NSPR's latest filing, up from $51.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $73.5 million in Q3 2025 and bottomed at $6.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $25.4 million, with a median of $21.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 1886.58% in 2021, then increased 1.0% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.3 million in 2021, then rose by 7.16% to $7.9 million in 2022, then soared by 208.29% to $24.3 million in 2023, then soared by 72.77% to $41.9 million in 2024, then soared by 75.22% to $73.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $73.5 million in Q3 2025, $51.0 million in Q2 2025, and $50.0 million in Q1 2025.